iHuman Inc.
IH NYSE· Services-Educational Services
KIRA · Stoqly’s AI analyst, in plain words
- iHuman Inc. had $112M of revenue in fiscal 2025, down 12.4% on the year before. Over five years, revenue changed +7.8% a year on average.
- Its operating margin was 8.3%, up 0.5 pts: of every 100 in sales, about 8 is left after running the business.
- iHuman Inc. made $13.3M of net profit in fiscal 2025.
- Free cash flow was $6.5M in fiscal 2025, 5.8% of revenue.
- iHuman Inc. returned $7.8M to shareholders in fiscal 2025, 121% of free cash flow. The diluted share count fell 1.3%.
Market cap
—
P/E
—
Revenue
$112M
Net income
$13.3M
Free cash flow
$6.5M
Operating margin
8.3%
iHuman Inc. in 30 seconds · fiscal 2025
Are sales growing?
−12.4%
No. Sales fell 12.4% last year.
Does it make a profit?
11.8%
Yes. It keeps 11.8% of every sale as profit.
Does profit turn into cash?
5.8%
Partly. 5.8% of sales ends up as free cash.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
What iHuman Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 24, 2026
- Legal name
- iHuman Inc.
- CIK
- 0001814423
iHuman Inc. · IH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $146M | $146M | $144M | $128M | $112M |
| Revenue growth | 90.1% | −0.1% | −1.8% | −10.9% | −12.4% |
| Gross margin | 69.9% | 70.1% | 70.8% | 69.4% | 67.9% |
| Operating margin | −5.7% | 11.3% | 15.7% | 7.8% | 8.3% |
| Net income | −$5.7M | $16.3M | $25.5M | $13.7M | $13.3M |
| Net margin | −3.9% | 11.1% | 17.8% | 10.7% | 11.8% |
| Diluted EPS | −$0.11 | $0.30 | $0.47 | $0.25 | $0.25 |
| Cash | |||||
| Cash from operations | $5.9M | $28.0M | $24.3M | $8.1M | $7.1M |
| Capital expenditure | $5.0M | $1.0M | $0.9M | $1.0M | $0.7M |
| Free cash flow | $0.9M | $27.0M | $23.4M | $7.1M | $6.5M |
| FCF margin | 0.6% | 18.5% | 16.3% | 5.5% | 5.8% |
| Dividends paid | — | — | — | $4.9M | $5.4M |
| Share buybacks | $0.0M | $1.0M | $1.3M | $1.3M | $2.4M |
| Share count change | 17.8% | 1.3% | 1.3% | −0.9% | −1.3% |
| Debt and strength | |||||
| Cash and short-term investments | $135M | $152M | $171M | $160M | $164M |
| Shareholders' equity | $95.8M | $112M | $135M | $132M | $142M |
| Current ratio | 2.1x | 2.2x | 2.8x | 3.0x | 3.6x |
| Returns and quality | |||||
| Return on equity | −5.9% | 15.7% | 20.7% | 10.3% | 9.7% |
| Return on tangible equity | −6.3% | 15.1% | 19.4% | 10.6% | 9.5% |
| Piotroski F-score | 5 | 6 | 5 | 4 | 4 |
| Altman Z'' | 2.9 | 4.6 | 6.5 | 6.6 | 7.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
iHuman Inc. · IH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001814423). Data updated October 24, 2026. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.